Global Disposable Endoscopes Market Is Anticipated To Reach US$ 9.26 Bn By 2032


The global market for disposable endoscopes market is anticipated to secure a market value of USD 9.26 Bn by 2032 while expanding at a CAGR of 16% during the forecast period from 2022 to 2032.  The reduced scope of spreading infections with the usage of disposable endoscopes is likely to increase the demand for the single-use endoscope in the coming time.

Increased incidence of HAI due to usage of infected endoscopes is likely to be another salient cause driving the market.  Moreover, the ongoing development with the rising investment by the renowned key disposable endoscope manufacturers is predicted to augment the industry significantly. In addition, the increasing clearances by the regulatory bodies are likely to provide a significant boost to the market in the coming time.

Request Sample

Key Takeaways from the Market Study

  • Global disposable endoscopes market to be valued at over US$ 2 Bn by 2022
  • By application, bronchoscopy to accumulate a revenue share worth over 28% in 2022
  • North America to dominate the global market. The region to have secured about 41% of the global market share in 2021.
  • Asia Pacific to be the fastest growing market, expected to flourish at a CAGR of 17%

“Reduced chances of spreading hospital acquired infections is likely to bode well for the demand for single-use endoscopes in forthcoming years,” – says an analyst at Fact. MR.

Competitive Landscape

The key players of the market opt for various strategies to enhance their global market reach. Acquisitions, partnerships, and collaborations are some of the methods adopted by the players.

Some of the recent developments among the key players are:

  • In June 2020, a private corporation that manufactures single-use endoscopes, 3NT, disclosed FDA 510 (K) clearance for Colibri™ Micro ENT Scope. It is the world’s first single-use endoscope planned especially for Otology.
  • In December 2021, Ambu Inc., the global leader in single-use endoscopes disclosed that it has been given a contract, which is to be effective from February 2022. The contract is in the field of Single-Use Visualization Devices with Vizient Inc., which is the largest healthcare performance Improvement Company in the U.S.
  • In November 2020, Olympus Corporation disclosed a partnership with Ruhof Corporation and launched hybrid tubing and single-use procedure kits for endoscopes to lessen the contamination risk.

Leave a Reply

Related Posts